FairValu
JOHNSON & JOHNSON

JOHNSON & JOHNSON

JNJNYSE
Drug Manufacturers - General • Healthcare•jnj.com
Current Price
$255.560.00%
Market Cap
$615.87B
Shares Outstanding: 2.41B
Volume
-
Avg Vol (3M): -
Next Earnings
-
52 Week Range
Low: $--High: $--

Latest results at a glance

Insights from the latest company results and reports · filed 15 Jul 2026

  • Q2 2026 Earnings Exceed Consensus

    Reported adjusted EPS of $2.90 per share for the quarter ended June 2026 exceeded the same-quarter consensus estimate of $2.85 per share.

  • 2026 Outlook Raised

    The company increased 2026 adjusted EPS guidance to a midpoint of $11.68, an increase of $0.13 from the prior guidance.

  • Gross Margin Expands Year-Over-Year

    Gross margin for the quarter ended June 28, 2026, was 68.19%, wider than the 67.87% recorded in the same quarter of the prior year.

AI-generated · updated 2 Oct 2026View source filing

Company research evidence

Checked financial measurements with the values, reporting periods and measurement basis shown together. This evidence is available independently of the AI report.

Loading evidence…

Deep Dive Research

Source-linked company research for JNJ

Revenue segmentation

Loading segment disclosures…